VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its Ventripoint Medical System produces critical heart information by processing standard information received from existing medical imaging equipment with its patented and proprietary methods incorporating Knowledge Based Reconstruction algorithms and proprietary cardiac databases. The company was founded by Joseph Ashley and Florence H. Sheehan on May 4, 2005 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Ventripoint Diagnostics Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ventripoint Diagnostics Ltd market cap is $21.58M.
What is the 52-week high for Ventripoint Diagnostics Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ventripoint Diagnostics Ltd 52 week high is $0.175 as of April 02, 2026.
What is the 52-week low for Ventripoint Diagnostics Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ventripoint Diagnostics Ltd 52 week low is $0.08 as of April 02, 2026.
What is Ventripoint Diagnostics Ltd stock price today?
Ventripoint Diagnostics Ltd stock price today is $0.115.
What was Ventripoint Diagnostics Ltd stock price yesterday?
Ventripoint Diagnostics Ltd stock price yesterday was $0.12.
What is the PE ratio of Ventripoint Diagnostics Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ventripoint Diagnostics Ltd's P/E ratio is -4.64.
What is the Price-to-Book ratio of Ventripoint Diagnostics Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ventripoint Diagnostics Ltd P/B ratio is -4.1412.
What is the 50-day moving average of Ventripoint Diagnostics Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ventripoint Diagnostics Ltd 50-day moving average is $0.1162.